Back
ESC Premium Access

Insights to patophysiology and risk factors of cardiac allograft vasculopathy: A prospective study using highly automated coronary optical coherence tomography segmentation software in 3D

Session: Impact of concomitant disease on coronary artery disease
Topic: CAD and comorbidities
Speaker: Associate Professor M. Pazdernik (Prague, CZ)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Michal Pazdernik

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)
7 presentations
4 followers

7 more presentations in this session

Long-term prognostic significance of diabetes mellitus according to renal function in myocardial infarction patients. The FAST-MI 2005 registry

Speaker: Doctor E. Puymirat (Paris, FR)

Access
Abstract
Slides
Video
Like
Thumbnail

Prevalence of genetically confirmed familial hypercholesterolemia in patients with acute coronary syndrome

Speaker: Doctor A. Amor Salamanca (Madrid, ES)

Access
Abstract
Like
Thumbnail

The interplay between Acute Coronary Syndrome and Atrial Fibrillation: Poor outcomes and longer hospital stay in a study of 18,444 patients

Speaker: Doctor M. Protty (Cwmbran, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Prevalence, management and prognostic impact on long-term mortality of familial hypercholesterolemia in patients with acute or stable coronary artery disease

Speaker: Doctor M. Tscharre (Wiener Neustadt, AT)

Access
Abstract
Slides
Video
Like
Thumbnail

Impact of non-cardiovascular multimorbidity after acute coronary syndrome

Speaker: Doctor S. Canivell (Lausanne, CH)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Impact of concomitant disease on coronary artery disease

Speakers: Associate Professor M. Pazdernik, Doctor E. Puymirat, Doctor A. Amor Salamanca, Doctor M. Protty, Doctor M. Tscharre...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

novartis Explore sponsored resources